CLARA EASTERLIN: Open Payments
NPI 1871364018 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,623 in 66 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $528 · 2025 $1,623
Food & beverage: $1,320Education: $303
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $523 |
| UCB, Inc. | 12 | $299 |
| Regeneron Healthcare Solutions, Inc. | 12 | $294 |
| ABBVIE INC. | 7 | $138 |
| GENZYME CORPORATION | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Incyte Corporation | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| Cipher Pharmaceuticals US LLC | 1 | $39 |
| Amgen Inc. | 1 | $21 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, COSENTYX, OPZELURA, TALTZ, Natroba.
Industry payments across TN — which companies pay providers there.
